Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0014 | 1 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.00074 | 1 |
mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.00056 | 1 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |